Validation of the French national health insurance information system as a tool in vaccine safety assessment: application to febrile convulsions after pediatric measles/mumps/rubella immunization.
暂无分享,去创建一个
S. Escolano | M. Hanf | P. Tubert-Bitter | E. Benzenine | C. Quantin | M. Velten | P. Farrington | N. M. Hocine
[1] Sheila Davey,et al. State of the world's vaccines and immunization , 2013 .
[2] S. Ozawa,et al. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review. , 2012, Vaccine.
[3] A. Weill,et al. French national health insurance information system and the permanent beneficiaries sample. , 2010, Revue d'epidemiologie et de sante publique.
[4] M. Gold,et al. Use of the Australian Childhood Immunisation Register for vaccine safety data linkage. , 2010, Vaccine.
[5] B. Bégaud,et al. Pharmacoepidemiological research using French reimbursement databases: yes we can! , 2010, Pharmacoepidemiology and drug safety.
[6] N. Andrews,et al. Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom. , 2007, American journal of epidemiology.
[7] J. Olsen,et al. MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis. , 2004, JAMA.
[8] P. Duclos. A global perspective on vaccine safety. , 2004, Vaccine.
[9] T. Jefferson,et al. Unintended events following immunization with MMR: a systematic review. , 2003, Vaccine.
[10] Robert T. Chen,et al. Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines , 2003, Expert review of vaccines.
[11] John W. Glasser,et al. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. , 2001, The New England journal of medicine.
[12] V. Pankratz,et al. Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study. , 2001, Vaccine.
[13] John W. Glasser,et al. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. , 1997, Pediatrics.
[14] S. Rosenthal,et al. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. , 1995, American journal of public health.
[15] A. Colville,et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines , 1995, The Lancet.
[16] A. Colville,et al. Risk of aseptic meningitis after measles, mumps,and rubella vaccine in UK children , 1993, The Lancet.
[17] N. Begg,et al. Role of epidemiology in vaccine policy. , 1990, Vaccine.
[18] D. Levy-bruhl,et al. Vaccination coverage estimated based on data found in 24th month health certificates of infants, France, 2004-2007. , 2010 .